Literature DB >> 3396955

Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease.

J Cox1, T K Daneshmend, C J Hawkey, R F Logan, R P Walt.   

Abstract

Azathioprine toxicity complicated the management of four patients with inflammatory bowel disease. All patients received the drug as adjunctive therapy to steroids when responses to the latter were poor. After a variable sensitising period the patients developed severe diarrhoea and abdominal pain and this was believed at first to be a manifestation of their underlying diseases but rechallenge with azathioprine reproduced the problem. During three episodes described emergency admission to hospital and resuscitation with intravenous fluids was required. The cases illustrate the difficulty clinicians have in recognising drug induced effects which mimic the underlying disease. When a patient suspects a reaction to azathioprine we believe any rechallenge should only be undertaken in the controlled hospital environment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396955      PMCID: PMC1433640          DOI: 10.1136/gut.29.5.686

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  7 in total

1.  Sensitivity to azathioprine.

Authors:  J O King; M C Laver; K F Fairley; G A Ames
Journal:  Med J Aust       Date:  1972-10-21       Impact factor: 7.738

2.  Life-threatening hypotension associated with azathioprine therapy. A case report.

Authors:  M Zaltzman; J Kallenbach; T Shapiro; M Lewis; V Fritz; H Reef; S Zwi
Journal:  S Afr Med J       Date:  1984-02-25

3.  Azathioprine-induced shock.

Authors:  T Cunningham; D Barraclough; K Muirden
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

Review 4.  Adverse effects of azathioprine.

Authors:  D H Lawson; G E Lovatt; C S Gurton; R C Hennings
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1984

5.  Hypersensitivity and jaundice due to azathioprine.

Authors:  M Davis; A L Eddleston; R Williams
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

6.  Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

Authors:  D P Jewell; S C Truelove
Journal:  Br Med J       Date:  1974-12-14

7.  Controlled trial of azathioprine in chronic ulcerative colitis.

Authors:  A P Kirk; J E Lennard-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01
  7 in total
  7 in total

Review 1.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 2.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.

Authors:  D G Bowen; W S Selby
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

4.  Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Authors:  A B Hawthorne; R F Logan; C J Hawkey; P N Foster; A T Axon; E T Swarbrick; B B Scott; J E Lennard-Jones
Journal:  BMJ       Date:  1992-07-04

5.  Case Report: Azathioprine: An Old and Wronged Immunosuppressant.

Authors:  Pedro R Chocair; Precil Diego Miranda de Menezes Neves; Sara Mohrbacher; Maurilio Pacheco Neto; Victor A H Sato; Érico S Oliveira; Leonardo V Barbosa; Alessandra M Bales; Fagner Pereira da Silva; Américo L Cuvello-Neto; John A Duley
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

6.  Gastrointestinal type 1 hypersensitivity to azathioprine.

Authors:  R R Riedel; A Schmitt; J P de Jonge; A Hartmann
Journal:  Klin Wochenschr       Date:  1990-01-04

Review 7.  Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.

Authors:  Bruno Rafael Ramos de Mattos; Maellin Pereira Gracindo Garcia; Julia Bier Nogueira; Lisiery Negrini Paiatto; Cassia Galdino Albuquerque; Caique Lopes Souza; Luís Gustavo Romani Fernandes; Wirla Maria da Silva Cunha Tamashiro; Patricia Ucelli Simioni
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.